Litcius/Paper detail

CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer

Erin M. Bange, Nicholas Han, Paul Wileyto, Justin Kim, Sigrid Gouma, James Robinson, Allison R. Greenplate, Madeline A. Hwee, Florence Porterfield, Olutosin Owoyemi, Karan Naik, Cathy Zheng, Michael Galantino, Ariel R. Weisman, C.A.G. Ittner, Emily M. Kugler, Amy E. Baxter, Olutwatosin Oniyide, R.S. Agyekum, Thomas Dunn, Tiffanie K. Jones, H.M. Giannini, Madison E. Weirick, Christopher M. McAllister, N. Esther Babady, Anita Kumar, Adam J. Widman, Susan DeWolf, Sawsan R. Boutemine, Charlotte Roberts, Krista R. Budzik, Susan Tollett, Carla Wright, Tara Perloff, Lova Sun, Divij Mathew, Josephine R. Giles, Derek A. Oldridge, Jennifer E. Wu, Cécile Alanio, Sharon Adamski, Alfred L. Garfall, Laura A. Vella, Samuel Kerr, Justine V. Cohen, Randall A. Oyer, Ryan Massa, Ivan Maillard, Kara N. Maxwell, John P. Reilly, P. Maslak, Robert H. Vonderheide, Jedd D. Wolchok, Scott E. Hensley, E. John Wherry, Nuala J. Meyer, Angela DeMichele, Santosha A. Vardhana, Ronac Mamtani, Alexander C. Huang

2021Nature Medicine520 citationsDOIOpen Access PDF

Topics & Concepts

MedicineCancerImmunologyImmune systemCD8ImmunityMalignancyInternal medicineCOVID-19 and healthcare impactsCOVID-19 Clinical Research StudiesCancer Immunotherapy and Biomarkers